Evaluation of the pharmacokinetic interaction and safety of ubrogepant coadministered with acetaminophen or nonsteroidal anti-inflammatory drugs: A randomized trial

• Main Authors: Abhijeet Jakate (Author), Ramesh Boinpally (Author), Matthew Butler (Author), Kaifeng Lu (Author), Kristi Womack (Author), Danielle McGeeney (Author), Antonia Periclou (Author)
• Format: Book
• Published: SAGE Publishing, 2020-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Ubrogepant is a novel, oral calcitonin gene-related peptide receptor antagonist approved by the US Food and Drug Administration for acute treatment of migraine with or without aura in adults. Objectives: To assess potential pharmacokinetic (PK) drug-drug interactions in healthy participa...